Aldeyra Therapeutics

$6.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.42 (-5.95%) As of 11:22 AM EDT today

Why Robinhood?

You can buy or sell ALDX and other stocks, options, and ETFs commission-free!

About ALDX

Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. Read More The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA. The listed name for ALDX is Aldeyra Therapeutics, Inc. Common Stock.

Employees
20
Headquarters
Lexington, Massachusetts
Founded
2004
Market Cap
254.98M
Price-Earnings Ratio
Dividend Yield
Average Volume
847.83K
High Today
$6.83
Low Today
$6.30
Open Price
$6.83
Volume
268.46K
52 Week High
$8.70
52 Week Low
$1.48

Collections

ALDX Earnings

-$0.72
-$0.48
-$0.24
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 5, Pre-Market

You May Also Like